{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T06:14:58Z","timestamp":1780121698017,"version":"3.54.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,11,1]]},"abstract":"<jats:sec>\n                  <jats:title>Background and Purpose<\/jats:title>\n                  <jats:p>The impact of cancer and its treatments on balance and functional mobility in older adults remains unknown but is increasingly important, given the evolution of cancer treatments. Subacute and more persistent side effects such as chemotherapy-induced peripheral neuropathy are on the rise, and the effects on mobility and balance, as well as the prognosis for resolution of any functional deficits, must be established before interventions can be trialed. The purpose of this case report is to describe the severity and long-term persistence of mobility decline in an older adult who received neurotoxic chemotherapy. To our knowledge, this is the first case report to describe an older adult with chemotherapy-induced peripheral neuropathy using results of standardized balance and mobility tests and to focus on prognosis by repeating these measures more than 2 years after chemotherapy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Case Description<\/jats:title>\n                  <jats:p>An 81-year-old woman received a neurotoxic agent (paclitaxel) after curative mastectomy for breast cancer. Baseline testing prior to taxane therapy revealed a socially active woman with no reported functional deficits or neuropathic symptoms, 1.2-m\/s gait speed, and performance at the ceiling on balance and gait portions of a standardized mobility measure.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Outcomes<\/jats:title>\n                  <jats:p>After 3 cycles, paclitaxel therapy was stopped by the oncologist because of neurotoxicity. Declines as large as 50% were seen in performance-based measures at 12 weeks and persisted at 2.5 years, and the patient reported recurrent falls, cane use, and mobility-related disability.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>This case highlights the extent to which function can decline in an older individual receiving neurotoxic chemotherapy, the potential for these deficits to persist years after treatment is stopped, and the need for physical therapy intervention and further research in this population.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2522\/ptj.20090405","type":"journal-article","created":{"date-parts":[[2010,9,3]],"date-time":"2010-09-03T00:55:32Z","timestamp":1283475332000},"page":"1649-1657","source":"Crossref","is-referenced-by-count":82,"title":["Persistent Mobility Disability After Neurotoxic Chemotherapy"],"prefix":"10.1093","volume":"90","author":[{"given":"Elizabeth S.","family":"Hile","sequence":"first","affiliation":[{"name":"E.S. Hile, PT, PhD, NCS, is Assistant Professor, Department of Physical Therapy, School of Health and Rehabilitation Sciences, University of Pittsburgh, 6035 Forbes Tower, Pittsburgh, PA 15260 (USA)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Kelley","family":"Fitzgerald","sequence":"additional","affiliation":[{"name":"G.K. Fitzgerald, PT, PhD, OCS, FAPTA, is Associate Professor, Department of Physical Therapy, School of Health and Rehabilitation Sciences, and Director, Physical Therapy Clinical and Translational Research Center, University of Pittsburgh."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Studenski","sequence":"additional","affiliation":[{"name":"S.A. Studenski, MD, MPH, is Professor, Department of Physical Therapy, Division of Geriatric Medicine, University of Pittsburgh, and Staff Physician, VA Pittsburgh Geriatric Research Education and Clinical Center."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"2020010205280059600_B1","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1200\/JCO.2005.00.141","article-title":"Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials","volume":"23","author":"Townsley","year":"2005","journal-title":"J Clin Oncol"},{"key":"2020010205280059600_B2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2522\/ptj.20070309","article-title":"A framework for assessment in oncology rehabilitation","volume":"89","author":"Gilchrist","year":"2009","journal-title":"Phys Ther"},{"key":"2020010205280059600_B3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1200\/JCO.1994.12.2.241","article-title":"Phase I trial of 3-hour infusion of paclitaxel with or without granulocyte colony-stimulating factor in patients with advanced cancer","volume":"12","author":"Schiller","year":"1994","journal-title":"J Clin Oncol"},{"key":"2020010205280059600_B4","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s005200050275","article-title":"Evaluation of neurotoxicity induced by paclitaxel second-line chemotherapy","volume":"7","author":"du Bois","year":"1999","journal-title":"Support Care Cancer"},{"key":"2020010205280059600_B5","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.2174\/092986708786848569","article-title":"Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies","volume":"15","author":"Park","year":"2008","journal-title":"Curr Med Chem"},{"key":"2020010205280059600_B6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11910-008-0010-5","article-title":"Chemotherapy-induced peripheral neuropathy","volume":"8","author":"Malik","year":"2008","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2020010205280059600_B7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF01999566","article-title":"Paclitaxel neurotoxicity: clinical and neurophysiological study of 23 patients","volume":"18","author":"Pace","year":"1997","journal-title":"Ital J Neurol Sci"},{"key":"2020010205280059600_B8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2407-6-5","article-title":"Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study","volume":"6","author":"Pignata","year":"2006","journal-title":"BMC Cancer"},{"key":"2020010205280059600_B9","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1212\/01.WNL.0000154642.45474.28","article-title":"Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening","volume":"64","author":"Verstappen","year":"2005","journal-title":"Neurology"},{"key":"2020010205280059600_B10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF00839140","article-title":"Cisplatin neuropathy: clinical course and neurophysiological findings","volume":"239","author":"LoMonaco","year":"1992","journal-title":"J Neurol"},{"key":"2020010205280059600_B11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1212\/01.WNL.0000043691.53710.53","article-title":"Toxic neuropathy in patients with pre-existing neuropathy","volume":"60","author":"Chaudhry","year":"2003","journal-title":"Neurology"},{"key":"2020010205280059600_B12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3122\/jabfm.17.5.309","article-title":"The prevalence, predictors, and consequences of peripheral sensory neuropathy in older patients","volume":"17","author":"Mold","year":"2004","journal-title":"J Am Board Fam Pract"},{"key":"2020010205280059600_B13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1745-7599.2004.tb00458.x","article-title":"Clinical evaluation and patterns of chemotherapy-induced peripheral neuropathy","volume":"16","author":"Visovsky","year":"2004","journal-title":"J Am Acad Nurse Pract"},{"key":"2020010205280059600_B14","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00520-005-0776-9","article-title":"Peripheral neuropathy induced by administration of cisplatin- and paclitaxel-based chemotherapy: could it be predicted?","volume":"13","author":"Argyriou","year":"2005","journal-title":"Support Care Cancer"},{"key":"2020010205280059600_B15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00520-005-0868-6","article-title":"Is advanced age associated with increased incidence and severity of chemotherapy-induced peripheral neuropathy?","volume":"14","author":"Argyriou","year":"2006","journal-title":"Support Care Cancer"},{"key":"2020010205280059600_B16","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1188\/07.CJON.901-913","article-title":"Putting evidence into practice: evidence-based interventions for chemotherapy-induced peripheral neuropathy","volume":"11","author":"Visovsky","year":"2007","journal-title":"Clin J Oncol Nurs"},{"key":"2020010205280059600_B17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/A:1005805907311","article-title":"Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing","volume":"35","author":"Forsyth","year":"1997","journal-title":"J Neurooncol"},{"key":"2020010205280059600_B18","first-page":"209","article-title":"Oxaliplatin (L-OHP): Global safety in 682 patients (abstract 513)","volume":"14","author":"Brienza","year":"1995","journal-title":"Proc Am Soc Clin Oncol"},{"key":"2020010205280059600_B19","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1200\/JCO.1994.12.11.2447","article-title":"Treatment tolerance of elderly cancer patients entered onto phase II clinical trials: an Illinois Cancer Center study","volume":"12","author":"Giovanazzi-Bannon","year":"1994","journal-title":"J Clin Oncol"},{"key":"2020010205280059600_B20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1529-8027.2000.00026.x","article-title":"Influence of aging on peripheral nerve function and regeneration","volume":"5","author":"Verdu","year":"2000","journal-title":"J Peripher Nerv Syst"},{"key":"2020010205280059600_B21","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1055\/s-2005-871329","article-title":"Medication and toxin-induced peripheral neuropathy","volume":"25","author":"Pratt","year":"2005","journal-title":"Semin Neurol"},{"key":"2020010205280059600_B22","doi-asserted-by":"crossref","first-page":"M85","DOI":"10.1093\/geronj\/49.2.M85","article-title":"A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission","volume":"49","author":"Guralnik","year":"1994","journal-title":"J Gerontol"},{"key":"2020010205280059600_B23","first-page":"21","article-title":"The Supplement on Aging to the 1984 National Health Interview Survey","author":"Fitti","year":"1987","journal-title":"Vital Health Stat 1"},{"key":"2020010205280059600_B24","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1001\/jama.1989.03420180087036","article-title":"Risk factors for recurrent nonsyncopal falls: a prospective study","volume":"261","author":"Nevitt","year":"1989","journal-title":"JAMA"},{"key":"2020010205280059600_B25","doi-asserted-by":"crossref","first-page":"M97","DOI":"10.1093\/geronj\/49.3.M97","article-title":"Predicting changes in physical performance in a high-functioning elderly cohort: MacArthur studies of successful aging","volume":"49","author":"Seeman","year":"1994","journal-title":"J Gerontol"},{"key":"2020010205280059600_B26","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1532-5415.1994.tb06535.x","article-title":"Development of a physical performance and mobility examination","volume":"42","author":"Winograd","year":"1994","journal-title":"J Am Geriatr Soc"},{"key":"2020010205280059600_B27","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJM199503023320902","article-title":"Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability","volume":"332","author":"Guralnik","year":"1995","journal-title":"N Engl J Med"},{"key":"2020010205280059600_B28","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1532-5415.2003.51104.x","article-title":"Physical performance measures in the clinical setting","volume":"51","author":"Studenski","year":"2003","journal-title":"J Am Geriatr Soc"},{"key":"2020010205280059600_B29","doi-asserted-by":"crossref","first-page":"M221","DOI":"10.1093\/gerona\/55.4.M221","article-title":"Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery","volume":"55","author":"Guralnik","year":"2000","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2020010205280059600_B30","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1023\/A:1008344507482","article-title":"Pitfalls in grading severity of chemotherapy-induced peripheral neuropathy","volume":"9","author":"Postma","year":"1998","journal-title":"Ann Oncol"},{"key":"2020010205280059600_B31","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1532-5415.2006.00701.x","article-title":"Meaningful change and responsiveness in common physical performance measures in older adults","volume":"54","author":"Perera","year":"2006","journal-title":"J Am Geriatr Soc"},{"key":"2020010205280059600_B32","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.pain.2004.01.021","article-title":"Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients","volume":"109","author":"Dougherty","year":"2004","journal-title":"Pain"},{"key":"2020010205280059600_B33","first-page":"295","article-title":"The environment and disease: association or causation?","volume":"58","author":"Hill","year":"1965","journal-title":"Proc R Soc Med"},{"key":"2020010205280059600_B34","first-page":"239","article-title":"Paraclinical evaluation of side-effects of Taxanes on auditory system","volume":"28","author":"Sarafraz","year":"2008","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"2020010205280059600_B35","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.apmr.2007.05.007","article-title":"Quantitative and clinical description of postural instability in women with breast cancer treated with taxane chemotherapy","volume":"88","author":"Wampler","year":"2007","journal-title":"Arch Phys Med Rehabil"},{"key":"2020010205280059600_B36","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1532-5415.1991.tb01616.x","article-title":"The timed \u201cup & go\u201d: a test of basic functional mobility for frail elderly persons","volume":"39","author":"Podsiadlo","year":"1991","journal-title":"J Am Geriatr Soc"},{"key":"2020010205280059600_B37","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1002\/(SICI)1097-0142(19971115)80:10<1973::AID-CNCR15>3.0.CO;2-V","article-title":"The impact of cancer on the physical function of the elderly and their utilization of health care","volume":"80","author":"Stafford","year":"1997","journal-title":"Cancer"},{"key":"2020010205280059600_B38","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1200\/JCO.2006.05.7224","article-title":"Lifestyle intervention development study to improve physical function in older adults with cancer: outcomes from Project LEAD","volume":"24","author":"Demark-Wahnefried","year":"2006","journal-title":"J Clin Oncol"},{"key":"2020010205280059600_B39","doi-asserted-by":"crossref","first-page":"M1119","DOI":"10.1093\/gerona\/58.12.M1119","article-title":"Function in elderly cancer survivors depends on comorbidities","volume":"58","author":"Garman","year":"2003","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2020010205280059600_B40","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1188\/05.CJON.189-193","article-title":"Case report: painful peripheral neuropathy following treatment with docetaxel for breast cancer","volume":"9","author":"Wampler","year":"2005","journal-title":"Clin J Oncol Nurs"},{"key":"2020010205280059600_B41","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(04)17666-6","article-title":"Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer","volume":"365","author":"Howell","year":"2005","journal-title":"Lancet"},{"key":"2020010205280059600_B42","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d: a practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"2020010205280059600_B43","first-page":"165","volume-title":"Geriatric Depression Scale (GDS): Recent Evidence and Development of a Shorter Version in Clinical Gerontology: A Guide to Assessment and Intervention","author":"Sheikh","year":"1986"}],"container-title":["Physical Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ptj\/article-pdf\/90\/11\/1649\/31674655\/ptj1649.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ptj\/article-pdf\/90\/11\/1649\/31674655\/ptj1649.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T10:28:39Z","timestamp":1577960919000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ptj\/article\/90\/11\/1649\/2737826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,1]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11,1]]}},"URL":"https:\/\/doi.org\/10.2522\/ptj.20090405","relation":{},"ISSN":["0031-9023","1538-6724"],"issn-type":[{"value":"0031-9023","type":"print"},{"value":"1538-6724","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,1]]}}}